Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.

× No keyword cloud information.

4 in total

Review 1. Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors: Marc Y Donath
Journal: Nat Rev Drug Discov Date: 2014-05-23 Impact factor: 84.694

2. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

Authors: Helga Ellingsgaard; Irina Hauselmann; Beat Schuler; Abdella M Habib; Laurie L Baggio; Daniel T Meier; Elisabeth Eppler; Karim Bouzakri; Stephan Wueest; Yannick D Muller; Ann Maria Kruse Hansen; Manfred Reinecke; Daniel Konrad; Max Gassmann; Frank Reimann; Philippe A Halban; Jesper Gromada; Daniel J Drucker; Fiona M Gribble; Jan A Ehses; Marc Y Donath
Journal: Nat Med Date: 2011-10-30 Impact factor: 53.440

3. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation.

Authors: Sardar Sindhu; Reeby Thomas; Puthiyaveetil Shihab; Devarajan Sriraman; Kazem Behbehani; Rasheed Ahmad
Journal: PLoS One Date: 2015-07-22 Impact factor: 3.240

Review 4. Targeting innate immune mediators in type 1 and type 2 diabetes.

Authors: Marc Y Donath; Charles A Dinarello; Thomas Mandrup-Poulsen
Journal: Nat Rev Immunol Date: 2019-09-09 Impact factor: 53.106

4 in total